5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.78▼ | 2.80▼ | 2.80▼ | 2.60▲ | 2.52▲ |
MA10 | 2.80▼ | 2.80▼ | 2.69▼ | 2.58▲ | 2.46▲ |
MA20 | 2.81▼ | 2.65▼ | 2.60▲ | 2.50▲ | 2.64▲ |
MA50 | 2.65▲ | 2.54▲ | 2.46▲ | 2.41▲ | 4.40▼ |
MA100 | 2.53▲ | 2.45▲ | 2.48▲ | 2.71▼ | N/A |
MA200 | 2.44▲ | 2.50▲ | 2.45▲ | 4.12▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.025▼ | -0.002▼ | 0.021▲ | 0.022▲ | 0.202▲ |
RSI | 42.771▼ | 49.693▼ | 53.030▲ | 56.252▲ | 38.888▼ |
STOCH | 31.977 | 59.622 | 82.670▲ | 57.719 | 67.486 |
WILL %R | -100.000▼ | -56.667 | -53.125 | -40.299 | -36.220 |
CCI | -233.892▼ | -51.000 | 28.975 | 152.679▲ | 102.672▲ |
Thursday, June 30, 2022 07:05 AM
LONDON, June 30, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors ...
|
Thursday, June 30, 2022 05:07 AM
LONDON, June 30, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors ...
|
Thursday, June 30, 2022 05:00 AM
Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the appointment of James Taylor as ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
07/07/22 | 2.74 | 2.76 | 2.65 | 2.65 | 46,722 |
06/07/22 | 2.55 | 2.92 | 2.50 | 2.82 | 206,482 |
05/07/22 | 2.4612 | 2.54 | 2.4612 | 2.53 | 4,445 |
01/07/22 | 2.50 | 2.53 | 2.41 | 2.49 | 7,975 |
30/06/22 | 2.4261 | 2.66 | 2.42 | 2.52 | 23,646 |
29/06/22 | 2.56 | 2.65 | 2.406 | 2.50 | 46,891 |
28/06/22 | 2.53 | 2.5999 | 2.5012 | 2.59 | 8,406 |
27/06/22 | 2.56 | 2.62 | 2.51 | 2.54 | 10,791 |
24/06/22 | 2.5999 | 2.60 | 2.48 | 2.59 | 32,964 |
23/06/22 | 2.52 | 2.60 | 2.45 | 2.56 | 10,751 |
|
|
||||
|
|
||||
|
|